IF 2.5 Q3 ENDOCRINOLOGY & METABOLISM
Claudia Reytor-González, Giuseppe Annunziata, Martín Campuzano-Donoso, Tania Morales-López, Carmen Basantes-Tituaña, Federica Fascì-Spurio, Ludovica Verde, Giovanna Muscogiuri, Luigi Barrea, Evelyn Frias-Toral, Daniel Simancas-Racines
{"title":"Endocrinologist's crucial role in metabolic dysfunction-associated steatotic liver disease: a comprehensive review.","authors":"Claudia Reytor-González, Giuseppe Annunziata, Martín Campuzano-Donoso, Tania Morales-López, Carmen Basantes-Tituaña, Federica Fascì-Spurio, Ludovica Verde, Giovanna Muscogiuri, Luigi Barrea, Evelyn Frias-Toral, Daniel Simancas-Racines","doi":"10.23736/S2724-6507.24.04314-8","DOIUrl":null,"url":null,"abstract":"<p><p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a widespread disorder strongly associated with metabolic conditions such as obesity, insulin resistance, and type 2 diabetes (T2D). The progression of MASLD, which can lead to severe complications like hepatic fibrosis and cirrhosis, is closely tied to cardiometabolic risks, including cardiovascular disease, and to liver-related cancers associated with metabolic dysfunction. Endocrinologists are uniquely positioned to detect MASLD early, particularly in individuals with metabolic risk factors such as T2D, polycystic ovary syndrome (PCOS), and thyroid dysfunction. While they may not routinely perform advanced diagnostic procedures, they play a critical role in identifying at-risk patients and collaborating with specialists for further evaluation, including the use of transient elastography to assess liver stiffness and fibrosis. By doing so, they help reduce the need for invasive procedures. Beyond screening and diagnosis, endocrinologists collaborate with hepatologists, cardiologists, and nutritionists to ensure a comprehensive, multidisciplinary treatment approach. Managing MASLD requires addressing both liver-specific conditions and broader metabolic dysfunctions through lifestyle interventions and pharmacological therapies. Recent studies highlight the potential benefits of medications, such as farnesoid X receptor (FXR) agonists and peroxisome proliferator-activated receptor (PPAR) agonists, when combined with lifestyle interventions such as modifying diet and engaging in more physical activity. This review highlights the pivotal role of endocrinologists in managing MASLD, focusing on their contributions to screening, diagnosis, and integrated care. It examines the complex interplay between hormonal regulation and both pharmacological and non-non-pharmacological treatment strategies, providing insights for enhancing clinical practice and improving patient outcomes through a comprehensive, multidisciplinary approach.</p>","PeriodicalId":18690,"journal":{"name":"Minerva endocrinology","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S2724-6507.24.04314-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

代谢功能障碍相关性脂肪性肝病(MASLD)是一种广泛存在的疾病,与肥胖、胰岛素抵抗和 2 型糖尿病(T2D)等代谢性疾病密切相关。脂肪肝的发展可导致肝纤维化和肝硬化等严重并发症,与心血管疾病等心脏代谢风险以及与代谢功能障碍相关的肝癌密切相关。内分泌科医生在早期发现 MASLD 方面具有得天独厚的优势,尤其是在具有代谢风险因素(如 T2D、多囊卵巢综合征 (PCOS) 和甲状腺功能障碍)的人群中。虽然他们可能不会常规执行高级诊断程序,但他们在识别高危患者并与专科医生合作进行进一步评估(包括使用瞬态弹性成像技术评估肝脏硬度和纤维化)方面发挥着至关重要的作用。这样做有助于减少对侵入性程序的需求。除了筛查和诊断外,内分泌专家还与肝病专家、心脏病专家和营养学家合作,确保采取全面的多学科治疗方法。管理MASLD需要通过生活方式干预和药物疗法来解决肝脏特异性疾病和更广泛的代谢功能障碍。最近的研究强调了药物治疗的潜在益处,如类法尼X受体(FXR)激动剂和过氧化物酶体增殖激活受体(PPAR)激动剂,如果与生活方式干预措施(如改变饮食习惯和参加更多体育锻炼)相结合,则会带来更多益处。本综述强调了内分泌科医生在管理 MASLD 方面的关键作用,重点介绍了他们在筛查、诊断和综合护理方面的贡献。它探讨了激素调节与药物和非药物治疗策略之间复杂的相互作用,为通过综合、多学科方法加强临床实践和改善患者预后提供了真知灼见。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Endocrinologist's crucial role in metabolic dysfunction-associated steatotic liver disease: a comprehensive review.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a widespread disorder strongly associated with metabolic conditions such as obesity, insulin resistance, and type 2 diabetes (T2D). The progression of MASLD, which can lead to severe complications like hepatic fibrosis and cirrhosis, is closely tied to cardiometabolic risks, including cardiovascular disease, and to liver-related cancers associated with metabolic dysfunction. Endocrinologists are uniquely positioned to detect MASLD early, particularly in individuals with metabolic risk factors such as T2D, polycystic ovary syndrome (PCOS), and thyroid dysfunction. While they may not routinely perform advanced diagnostic procedures, they play a critical role in identifying at-risk patients and collaborating with specialists for further evaluation, including the use of transient elastography to assess liver stiffness and fibrosis. By doing so, they help reduce the need for invasive procedures. Beyond screening and diagnosis, endocrinologists collaborate with hepatologists, cardiologists, and nutritionists to ensure a comprehensive, multidisciplinary treatment approach. Managing MASLD requires addressing both liver-specific conditions and broader metabolic dysfunctions through lifestyle interventions and pharmacological therapies. Recent studies highlight the potential benefits of medications, such as farnesoid X receptor (FXR) agonists and peroxisome proliferator-activated receptor (PPAR) agonists, when combined with lifestyle interventions such as modifying diet and engaging in more physical activity. This review highlights the pivotal role of endocrinologists in managing MASLD, focusing on their contributions to screening, diagnosis, and integrated care. It examines the complex interplay between hormonal regulation and both pharmacological and non-non-pharmacological treatment strategies, providing insights for enhancing clinical practice and improving patient outcomes through a comprehensive, multidisciplinary approach.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.60
自引率
0.00%
发文量
146
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信